Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Rheumatology

• Publication date

  2000-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 10743799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical guidelines for management.

  1997cited by this paper
• Specialist management: needs and benefits.

  1997cited by this paper
• Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial.

  1997cited by this paper
• Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study.

  1997cited by this paper
• What is early rheumatoid arthritis?: definition and diagnosis.

  1997cited by this paper
• Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.

  1997cited by this paper
• Direct medical costs unique to people with arthritis.

  1997cited by this paper
• Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

  1997cited by this paper
• The Effectiveness of Early Treatment with Second-Line Antirheumatic Drugs

  1996cited by this paper
• Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.

  1996cited by this paper
• Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies.

  1996cited by this paper
• The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group.

  1995cited by this paper
• American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

  1995cited by this paper
• Early rheumatoid arthritis: time to aim for remission?

  1995cited by this paper
• Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis.

  1995cited by this paper
• A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study.

  1995cited by this paper
• Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.

  1995cited by this paper
• Functional disability in early rheumatoid arthritis: description and risk factors.

  1994cited by this paper
• Progression of functional disability in patients with rheumatoid arthritis. Associations with rheumatology subspecialty care.

  1993cited by this paper
• Hydroxychloroquine Is Safe and Probably Useful in Rheumatoid Arthritis

  1993cited by this paper
• Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study.

  1993cited by this paper
• Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial.

  1993cited by this paper
• Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group.

  1992cited by this paper
• Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis.

  1991cited by this paper
• Rheumatoid arthritis. Pathophysiology and implications for therapy.

  1990cited by this paper
• The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two metaanalyses.

  1990cited by this paper
• Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group.

  1990cited by this paper
• Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.

  1988cited by this paper
• The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis.

  1987cited by this paper
• The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.

  1982cited by this paper
• Measuring health status in arthritis. The arthritis impact measurement scales.

  1980cited by this paper

• Management of Rheumatoid Arthritis By Development of Nanocarriers and their Significance Over Conventional Dosage Forms.

  2024cites this paper
• Reporting of Determinants of Health Inequities in Rheumatoid Arthritis Randomized Controlled Trials in Canada: A Scoping Review

  2022cites this paper
• Xylopic acid Suppresses Adjuvant-induced Arthritis in Sprague Dawley rats via Reduction in Serum Levels of IL-6 And TNF-alpha.

  2022cites this paper
• Rheumatoid Arthritis: Early Diagnosis and Treatment.

  2022cites this paper
• Unique autoantibody prevalence in long-term recovered SARS-CoV-2-infected individuals

  2021cites this paper
• Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial

  2021cites this paper
• Rheumatoid Arthritis: Early Diagnosis and Treatment.

  2021cites this paper
• The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions

  2021influential citation
• Disease Modifying Anti Rheumatic Drugs in Sudanese Patients with Rheumatoid Arthritis

  2020cites this paper
• Factors contributing to disability in rheumatoid arthritis patients: An Egyptian multicenter study.

  2020cites this paper
• Efficacy and safety of low-dose glucocorticoids combined with methotrexate and hydroxychloroquine in the treatment of early rheumatoid arthritis

  2020cites this paper
• Management der frühen rheumatoiden Arthritis

  2020cites this paper
• Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?

  2020cites this paper
• Window of opportunity in rheumatoid arthritis – definitions and supporting evidence: from old to new perspectives

  2019cites this paper
• Management of rheumatoid arthritis: 2019 updated consensus recommendations from the Hong Kong Society of Rheumatology

  2019cites this paper
• Verbesserung der Prognose durch frühzeitige Therapie

  2019cites this paper
• The Efficacy and Safety of Mainstream Medications for Patients With cDMARD-Naïve Rheumatoid Arthritis: A Network Meta-Analysis

  2018cites this paper
• Hybrid Photoacoustic/Ultrasound Tomograph for Real-Time Finger Imaging.

  2017cites this paper
• Use of Non Biologic DMARD in Rheumatoid Arthritis with Emphasis on Leflunomide

  2017cites this paper
• Chapter 71 – Treatment of Rheumatoid Arthritis

  2017cites this paper
• Experience of Biological Agents Usage in Patients with Rheumatoid Arthritis from a Western Indian Center

  2016cites this paper
• Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.

  2016cites this paper
• From Symptoms to Diagnosis: An Observational Study of the Journey of Rheumatoid Arthritis Patients in Saudi Arabia.

  2016cites this paper
• Predicting Response to Therapy for Autoimmune and Inflammatory Diseases Using a Folate Receptor-Targeted Near-Infrared Fluorescent Imaging Agent

  2016cites this paper
• Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohorts

  2015cites this paper
• Antimalarial Drugs Alone May Still Have a Role in Rheumatoid Arthritis

  2015cites this paper
• Frühdiagnostik der rheumatoiden Arthritis

  2015cites this paper
• 1H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis

  2015cites this paper
• Prediction of Response to Therapy for Autoimmune/Inflammatory Diseases Using an Activated Macrophage-Targeted Radioimaging Agent.

  2015cites this paper
• DMARD use in rheumatoid arthritis: can we predict treatment response?

  2015cites this paper
• REVISTA BRASILEIRA DE REUMATOLOGIA

  2014cites this paper
• A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089

  2014cites this paper
• Эффективность и безопасность лефлуномида* при ревматоидном артрите в реальной клинической практике (результаты Российского наблюдательного многоцентрового исследования)

  2014cites this paper
• REUMATOLOGICHE XXVI CICLO DYNAMIC AUTOMATED SYNOVIAL IMAGING ( DASI ) FOR DIFFERENTIATING BETWEEN RHEUMATOID AND PSORIATIC ARTHRITIS : AUTOMATED VERSUS MANUAL INTERPRETATION IN CONTRAST-ENHANCED ULTRASOUND

  2014cites this paper
• Proof‐of‐Concept Study of a Web‐Based Methotrexate Decision Aid for Patients With Rheumatoid Arthritis

  2014cites this paper
• The surgical treatment of rheumatoid arthritis: a new era?

  2014cites this paper
• A detailed analysis of treatment delay from the onset of symptoms in early rheumatoid arthritis patients

  2014cites this paper
• Rheumatoid arthritis: should we shift the focus from “Treat to Target” to “Treat to Work?”

  2013cites this paper
• Ф.С. Мусина, П.Д. Болотов, Р.Т. Хамидуллин, Т.А. Мельникова, Э.Г. Муталова ЛЕФЛУНОМИД В СОВРЕМЕННОЙ ПАТОГЕНЕТИЧЕСКОЙ ТЕРАПИИ РЕВМАТИЧЕСКИХ ЗАБОЛЕВАНИЙ ГБОУ ВПО «Башкирский государственный медицинский университет» Минздрава России, г. Уфа

  2013cites this paper
• Guidelines for the drug treatment of rheumatoid arthritis.

  2013cites this paper
• Diretrizes para o tratamento da artrite reumatoide Guidelines for the drug treatment of rheumatoid arthritis

  2013cites this paper
• Distinguishing erosive osteoarthritis and calcium pyrophosphate deposition disease.

  2013cites this paper
• Rheumatoid arthritis--early diagnosis and disease management.

  2013cites this paper
• Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?

  2013cites this paper
• Diretrizes para o tratamento da artrite reumatoide

  2013cites this paper
• Small Molecule DMARD Therapy and Its Position in RA Treatment

  2013cites this paper
• Lag time between disease onset and first visit to a tertiary rheumatology centre by patients with rheumatoid arthritis

  2013cites this paper
• Assessing the impact of rheumatoid arthritis on quality of life in a group of patients attending a rheumatology clinic in Sri Lanka

  2013cites this paper
• Biologics in RA

  2012cites this paper
• ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ГИДРОКСИХЛОРОХИНА ИММАРДА ПРИ РЕВМАТОИДНОМ АРТРИТЕ ПО ДАННЫМ ОТКРЫТОГО НЕКОНТРОЛИРУЕМОГО ИССЛЕДОВАНИЯ В АМБУЛАТОРНОЙ ПРАКТИКЕ

  2012cites this paper
• Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study

  2012cites this paper
• Early Rheumatoid Arthritis

  2012cites this paper
• Pursuit of optimal outcomes in rheumatoid arthritis

  2012cites this paper
• Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials

  2012cites this paper
• Psychological adjustment to the onset of rheumatoid arthritis : a longitudinal evaluation of perceptions of, and adherence to, medication

  2012cites this paper
• Interdisziplinäre Leitlinie Management der frühen rheumatoiden Arthritis

  2011cites this paper
• Artrite reumatoide: uma visão atual

  2011cites this paper
• Time to Treatment for New Patients with Rheumatoid Arthritis in a Major Metropolitan City

  2011cites this paper
• Quality care in seniors with new‐onset rheumatoid arthritis: A Canadian perspective

  2011cites this paper
• Management of rheumatoid arthritis

  2011cites this paper
• MODELS OF CARE IN ARTHRITIS: OVERVIEW OF THE NEED FOR MODELS OF CARE

  2010cites this paper
• [Does early treatment of Rheumatoid Arthritis lead to a better long-term prognosis?].

  2010cites this paper
• El control precoz de la artritis reumatoide augura un mejor pronóstico a largo plazo

  2010cites this paper
• [Does early treatment of Rheumatoid Arthritis lead to a better long-term prognosis?].

  2010cites this paper
• Factors determining a DMARD initiation in early inflammatory arthritis patients. The ESPOIR cohort study.

  2009cites this paper
• Drug management of early rheumatoid arthritis - 2008.

  2009cites this paper
• Relative Efficacies: Antimalarials to Abatacept – The Choice Is Ours

  2009cites this paper
• Adalimumab response in patients with early versus established rheumatoid arthritis: DE019 randomized controlled trial subanalysis

  2009cites this paper
• Work Capacity and Productivity Costs in Early Rheumatoid Arthritis: A Five-year Prospective Study

  2009cites this paper
• Treatment of Rheumatoid Arthritis

  2009cites this paper
• Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis

  2009cites this paper
• Le Rituximab dans le traitement de la polyarthrite rhumatoïde réfractaire aux inhibiteurs du facteur de nécrose tumorale (TNF)-Alpha

  2009cites this paper
• Adalimumab for early rheumatoid arthritis

  2008cites this paper
• The development of novel therapies for rheumatoid arthritis

  2008cites this paper
• The pattern and clinical manifestations of rheumatoid arthritis in Sarawak General Hospital

  2008cites this paper
• Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis

  2008cites this paper
• Historical and Current Perspectives on Management of Osteoarthritis and Rheumatoid Arthritis

  2008cites this paper
• PHYSICAL ACTIVITY AND HEALTH PERCEPTION IN INFLAMMATORY JOINT DISEASE A PHYSIOTHERAPY PERSPECTIVE

  2008cites this paper
• Advanced imaging in rheumatoid arthritis

  2007cites this paper
• Rheumatoid Arthritis : Pathogenesis , Clinical Features , and Treatment

  2007cites this paper
• Advanced imaging in rheumatoid arthritis

  2007cites this paper
• Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis

  2007cites this paper
• Joint Destruction in Rheumatoid Arthritis: Experimental, Clinical and Epidemiological Studies

  2007cites this paper
• Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment

  2007cites this paper
• CD28null T cells in rheumatoid arthritis and inflammatory myopathies : Cellular characterization and clinical relevance

  2007cites this paper
• [Early arthritis].

  2007cites this paper
• Management of early rheumatoid arthritis.

  2007cites this paper
• Are the 2002 American College of Rheumatology guidelines for the management of rheumatoid arthritis being followed in Canada's largest academic rheumatology center?

  2007cites this paper
• The Italian registry of aggressive rheumatoid arthritis -- the GIARA project.

  2007cites this paper
• Advanced imaging in rheumatoid arthritis. Part 1: synovitis.

  2007cites this paper
• L' APPROCCIO ORTOPEDICO-REUMATOLOGICO ALL'AMMALATO REUMATOIDE: L'ESPERIENZA FERRARESE

  2007cites this paper
• Studies Including Therapeutics (ESCISIT) Standing Committee for International Clinical early arthritis: report of a task force of the European EULAR recommendations for the management of

  2007cites this paper
• Effects of Sulfasalazine Treatment in Juvenile Idiopathic Arthritis: Clinical and Radiological Observations

  2007cites this paper
• A retrospective analysis of low-field strength magnetic resonance imaging and the management of patients with rheumatoid arthritis

  2007cites this paper
• Clinical laboratory testing in human medicine based on the detection of glycoconjugates.

  2007cites this paper
• Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis.

  2007cites this paper
• Factors associated with permanent work disability in Mexican patients with rheumatoid arthritis. A case-control study.

  2006cites this paper
• Magnetic resonance imaging of the hand for the diagnosis of rheumatoid arthritis in the absence of anti-cyclic citrullinated peptide antibodies: a prospective study.

  2006cites this paper
• A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis.

  2006cites this paper
• Ultrasound detects rapid progression of erosive disease in early rheumatoid arthritis: a prospective longitudinal study

  2006cites this paper